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Summary
The present study demonstrates that murine dermal fibroblasts produce nitrite (N02 - ) and
nitrate (N03 - ) upon treatment with interferon y (IFN-y) . This formation is dependent on
L-arginine and can be inhibited by the L-arginine analogue NG-monomethyl-L-arginine. The effect
ofIFN-y is drastically increased by cotreatment with tumor necrosis factor a (TNF-a), interleukin
1 (IIr1), or lipopolysaccharide (LPS). The tested cytokines also induce formation of tetrahy-
drobiopterin in murine fibroblasts. Inhibition of guanosine triphosphate-cyclohydrolase I, the
key enzyme of tetrahydrobiopterin de novo synthesis with 2,4-diamino-6-hydroxy-pyrimidine,
leads to decreased formation of N02- and N03 - . This effect can be reversed by addition of
sepiapterin, which provides tetrahydrobiopterin via a salvage pathway. Methotrexate, which inhibits
the salvage pathway, blocks the restoration of N02 - and N03 - production by sepiapterin. The
cytotoxic effect of combinations ofIFN-a with TNF-y, IW, or LPS is attenuated by inhibition
of tetrahydrobiopterin synthesis. These results show that intracellular concentrations of tetra-
hydrobiopterin control the amount of N02 - and N03 - produced in situ and suggest that the
role of cytokine-induced tetrahydrobiopterin synthesis is to provide cells with the active cofactor
for production of nitrogen oxides.
O
ne of the metabolic actions of IFN-y on human cells
in vitro is an up to 100-fold stimulation of guanosine
triphosphate (GTP)t-cyclohydrolase I (EC 3.5.4.16) activity
(1). This enzyme cleaves GTP to 7,8-dihydroneopterin tri-
phosphate, thus initiating the formation of 7,8-dihydro-
neopterin and 5,6,7,8-tetrahydrobiopterin (2). Both com-
pounds can be detected in cell homogenates of IFN-y treated
human macrophages, human fibroblasts, and a panel ofhuman
tumor cell lines (1). We showed previously that further en-
zyme activities required for the formation of tetrahydrobi-
opterin, i.e., 6-pyruvoyl tetrahydropterin synthase and sepi-
apterin reductase (EC 1.1.1.153), are not influenced by IFN-'Y,
but are constitutively present in the cells (3). IFN-y-induced
stimulation of GTP-cyclohydrolase I activity is enhanced by
cotreatment with TNF-a, LPS, or dexamethasone. This was
demonstrated for human fibroblasts, human macrophages and
the monocytic cell line THP-1(4, 5). In vivo, cytokine-induced
stimulation of GTP-cyclohydrolase I is indicated by elevated
neopterin excretion, which is related with diseases challenging
the cell-mediated immune system (6, 7).
Synthesis of tetrahydrobiopterin was also observed in mu-
Abbreviations used in this paper: DAHP, 2,4-diamino-6-hydroxy-
pyrimidine; GTP, guanosine triphosphate; NM, NG-monomethyl-L-
arginine; NOZ-, nitrite; NO3- , nitrate.
rine macrophages (8, 9). Further, we found recently in mouse
dermal fibroblasts that tetrahydrobiopterin synthesis is stimu-
lated by IFN-y and even better by TNF-a, or combination
of IFN-y with TNF-a (Werner, E. R., G. Werner-Felmayer,
D. Fuchs, A. Hausen, G. Reibnegger, J. J. Yim, and H.
Wachter, manuscript submitted for publication) .
Although cytokine-induced pteridine synthesis thus seems
to be a general phenomenon in mammalian cells, no biolog-
ical function could so far be established. Tetrabydrobiopterin
is an essential cofactor of phenylalanine 4-, tyrosine 3-, and
tryptophan 5-monooxygenase (10). However, we could not
find that these enzyme activities were induced in IFN-y-treated
cells (unpublished data). Moreover, there is no evidence that
oxidation of etherlipids, the fourth established tetrahydro-
biopterin-dependent reaction (11), is influenced by IFN-y.
Recently, a new tetrahydrobiopterin-requiring reaction, the
formation of nitrogen oxides from L-arginine, was described
for cell homogenates of mouse macrophages (8, 9) . This oxi-
dation of L-arginine is induced in murine macrophages by
treatment with LPS (12) or lymphokines, such as IFN-y (13).
The effect of IFN-y can be further enhanced by cotreatment
with TNF-a, TNF-a, or LPS (14, 15). Since pteridine syn-
thesis is modulated by the same factors, it appeared attractive
to hypothesize that cytokines induce formation oftetrahydrobi-
opterin in order to provide a cofactor for the generation of
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mation of nitrogen oxides should not only occur in macro-
phages but also in other cells with inducible pteridine syn-
thesis, e.g., in fibroblasts.
In this report, we show that murine fibroblasts canbe stim-
ulated by IFN-y to release nitrite (N02-) and nitrate
(N03 -). The effect of IFN-y is enhanced by TNF-ac, IL1,
or LPS. Data obtained by inhibition and restoration of pteri-
dine synthesis indicate that tetrahydrobiopterin is essential
for the formation of N02- and N03-, and that generation
of nitrogen oxides is related to cytokine-mediated cytotoxicity.
Materials and Methods
Materials.
￿
MouserIFN-y (producedin Chinese hamster ovary
cells) was obtained from Holland Biotechnology (Leiden, The
Netherlands) and had a specific activity of 10' U/mg of protein.
Mouse ffNF-a (4 x 10' U/mg protein; produced in Escherichia
coli wasakind gift of Dr.G.R. Adolph (BenderCo., Vienna, Aus-
tria). HumanrIIrl-a (10' U/mg protein; expressedin E. colt) was
from Genzyme (Boston, MA). LPS from E. coli 055:B5 (phenolic
extract), 2,4-diamino-6-hydroxy-pyrimidine (DAHP), andmetho-
trexate were from Sigma Chemical Co. (Munich, FRG). N'G-mono-
methyl-L-arginine (NMA) was from Calbiochem-Behring Corp.
(LaJolla, CA). Pteridines were from Dr. B. Schircks aona, Swit-
zerland).
Cell Culture.
￿
Murine fibroblasts were kindly provided by Dr.
C. Heufler(Department ofDermatology, University ofInnsbruck).
Cells were established from ear dermis explants of 8-10-wk-old
BALB/c mice, which were cultured in RPMI 1640 (Biochrome,
Berlin, FRG) containing 10% heat-inactivated FCS (Biochrome),
2 mM L-glutamine,100 U/ml ofpenicillin, and0.1 ng/mlofstrep-
tomycin (Sigma Chemical Co.). All cultures were maintained in
humidified air containing 5% C02 at 37°C with a medium
change every week. Nonadherent cells were removedby washing.
After 4 wk, cells grown out from the explants were passaged by
trypsinization andfurther propagated by a weekly transfer of 1:3.
Cells were determined to be fibroblasts dueto morphologicalfea-
tures, growth characteristics, and MHC antigen expression. The
resulting cell population, forming a monolayer, consisted of mul-
tipolar cells, assuming a pavement-like and partly spindle-shaped
appearance when confluent, as is characteristic for mouse fibro-
blasts. Cells ceased to grow when confluent, and no formationof
foci was observed. For isolation and culture of cells, no pretreat-
ment of surfaces or supply with growth factors except FCS was
provided. Under these standard conditions, only fibroblasts sur-
vive in the culture. MHC class I antigenexpression of these cells
was enhanced two- to threefold by IFN-y (5-500 U/ml) as com-
pared with untreated controls and untreated control cells, and
IFN-y-stimulated cells were negative for MHC class II antigen.
This wasreported previously for3T3mousefibroblasts (16). MHC
antigenexpression wasdetectedby ELISA as performedpreviously
(17). Cells grown in 96-well plates were stained with either un-
diluted supernatant from 34-1-2S hybridoma (Kd, Dd; American
Type Culture Collection, Rockville, MD) or with 20 ng/well of
purified antibody reacting with I-Ad (Becton Dickinson & Co.,
Mountain View, CA)andwith ahorseradish peroxidase-conjugated
second antibody to mouse IgG whole molecule (Sigma Chemical
Co.). Cells of passages 10-25 were used for experiments.
Formation of NOz- and NOZ- + N0,,-.
￿
Fibroblasts were
seeded at a density of 1( 5/ml in 24-well culture plates (Falcon Lab-
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ware, Oxnard, CA) and grown to confluency with onechange of
medium on day4 of culture, using RPMI 1640 (supplemented as
describedabove). On day8, cellswere treatedwithcytokines and/or
other additives. Due to its low content of nitrate, allincubations
were carriedoutin DMEM (Serva, Heidelberg, FRG),supplemented
as describedabove. We tested different dosesofDAHP (1-10mM),
sepiapterin (50-400,AM),andmethotrexate (10-100 uM). Optimal
doseswere 5 mM for DAHP, 100 AM for sepiapterin, and 10 AM
formethotrexate, andwere used throughout allfurther experiments.
Accordingly, otherpteridines were used at aconcentration of 100
AM. In the case of methotrexate treatment, the medium was sup-
plementedwith 40 AM thymineand100AMinosine (Fluka,Buchs,
Switzerland).Alladditiveswere dissolvedin complete DMEM, and,
where necessary, thepH was adjusted to 7.4. The additives were
applied to cellsjust before cytokines. In thecase ofcytokine com-
binations, TNF-a, IIA, or LPSwere added immediately afterIFN-y
(i.e., within 1 min), whichwas essentialfor optimal stimulation.
The final volume per well was 1 ml. NMA was applied to cells
24 h before stimulation with cytokines.
For some experiments, confluent monolayers were treated for
7h with cultured medium with or withoutL-arginine (MEM/Earle,
Select Amine Kit; Gibco Laboratories, Grand Island, NY), con-
tainingserum, glutamine, andantibiotics (see above). Afterchanging
the respective medium once again, cells were stimulated with
cytokines.
After incubation for 72 h, supernatants were harvested.
Monolayers were washed once with warm PBSandwere lysedwith
0.05 M H3P04 for protein determination. N02- was measured
in supernatants as described (18), using the stable Griess-Ilosvay's
nitrite reagent obtained from Merck (Darmstadt, FRG). N03
wasreducedenzymaticallyby 0.125 Wmol/min of nitrate reductase
(EC1.6.6.2)fromAspergillus sp. (Serva), and2.5 mM nicotinamide
adenine dinucleotide phosphate, reducedform, andwas then mea-
sured as N02- (designated NOz- + N03-). Background levels
were determined in cell-free controls of culture medium with or
without additives andwere subtracted forcalculation of the total
amount of nitrogen oxides formed. Data are presented as micro-
moles per liter. The detection limit of N02- was 1 Amol/liter.
Approximate values in nanomoles per milligram of total cell pro-
tein or nanomoles per 105 cells canbe calculated from the protein
values given below.
Determination ofIntracellular Biopterin.
￿
Fibroblasts were seeded
in 25-CM2 culture flasks (Falcon Labware) at a density of 105/ml
in 5 ml of complete RPMI 1640 and grown to confluency with
one medium change. On day 8, cells were treated with cytokines,
DAHP, methotrexate, and sepiapterin in a final volume of 5 ml
of complete DMEM (for details, see above). After72 h, superna-
tants were collected for detection of N02- and N02- + N03-
(see above). Absolute values of nitrogen oxides presentedin Table
2 (see Results) are higher than in the other experiments shown.
This was due to the use of culture flasks (25 cmz/5 ml) instead
of 24-wellplates (2 cmz/ml), resultingin a different cell to super-
natant ratio.
Cells were harvested by trypsinization and washed with PBS.
Pelletswere resuspended in 250Al ofdistilled water, rapidly frozen
in liquid nitrogen, andkept at -20°C untiloxidation, which was
startedwithin 1 h afterfreezing.Sampleswere thawed oneby one,
centrifuged for 2min at 10,000,g, andsubjected to oxidationwith
iodine at acidic or alkaline pH (19). Briefly, 100 Al ofcell extracts
were mixed with 5 A1 of 1 M HCl and 5 Al of 0.1 M K1/12 in
orderto determinethetotalamount ofbiopterin, including5,6,7,8-
tetrahydro and 7,8-dihydro derivatives. Another 100 Al of cell ex-
tract was mixed with 5 AI of 1 MNaOH and 5 141 of 0.1 M KI/Izfor destroying the tetrahydro derivative, thus detecting the sum
of 7,8-dihydrobiopterin and biopterin. After incubation for 1 h in
the dark at room temperature, samples were centrifuged for 2 min
at 10,000 g, and the supernatant was mixed with 10 Al of 0.1 M
ascorbic acid. Samples were stored at -20°C until HPLC analyses
(LC 5500; Varian Associates, Inc., No Alto, CA). Samples were
then extracted with AASPSCX cartridges (Analytichem Interna-
tional, Inc., Harbor City, CA), and pteridines were directly eluted
onto a reversed-phase HPLC column (Lichrosorb, RP-18, 7-,urn par-
ticle size, Merck) and quantifiedby fluorescence detection (LS 4,
Perkin-Elmer Corp., Beaconsfield, UK), as previously described (20).
Values are presented as picomoles per milligram of total cell protein.
Cell Viability Assay.
￿
Fibroblasts (105/ml) were seeded in 100
Al/well in 96-well plates (Falcon Labware) and grown to confluency,
using RPMI 1640 with supplements. We used confluent monolayers
in order to limit possible effects of additives on cell growth. On
day 8 ofculture, monolayers were treated with cytokines, DAHP,
and pteridinesin DMEM(see above) in a final volumeof 100 Al/well
for 48-96 h. In some experiments, the influence of L-arginine-
deficient medium, of 250 Am NMA, of 10 MM L- or D-arginine,
and of NMA plus 10 MM. L- or D-arginine was tested. For this
purpose, confluent monolayers were pretreatedwith the mentioned
additives 48 h before addition ofcytokines in the respective culture
medium. After 48-96 h, medium was removed, and cells were
washed once with 100 pl/well of warm PBS and fixed then with
5% glutaraldehyde in PBS (100 A1/well) for 10 min. Plates were
washed threetimes with PBS. Fixed cells were stained with 0.05%
methylene blue (Merck) for 5 min and washedfive times with PBS.
Methylene blue, trapped in fixed cells, was solubilized with 100
Al/well of 0.33 M HCI, and OD at 620 nm was measured using
a 96-well plate reader (Anthos; Labtec, Salzburg, Austria). Rela-
tive cell viability is expressed as percent ofuntreated control cells.
For each tested combination of factors, eight wells per platewere
treated in parallel. In comparison with 24-well plates (2 cmz/ml)
used in the other experiments, cytotoxic effects could be observed
earlier (i.e., after 72-% h) in %-well plates (0.32 cmz/100 Al) due
to a different cell to supernatant ratio. N02 - was determined in
supernatants of individual wells as described above.
Protein Determination.
￿
Protein content of cell extracts was de-
termined according to Bradford (21), modified for 96-well plates,
using the protein dye reagent from Bio-Rad Laboratories (Rich-
mond, CA) and BSA (Serva) as protein standard. Individualwells
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ofcontrol cells contained 76.6 t 7.7 pg (mean of 12 cultures ±
SD) ofprotein, whichwas not reduced >10% by cytokine treatment
for 72 h using 24-well plates and 1 ml ofculture medium. Protein
content of 105 cells was 25.4 ± 2.5 Wg (mean of 10 cultures ±
SD), so that the final cell number per well was N3 x 105.
Results
Induction of N02 - and NO., - Formation in Murine Fibro-
blasts by Cytokines. Murine fibroblasts produced N02- and
N03- upon treatment with IFN--y in a dose-dependent
manner (Fig. 1). The effect ofIFN-y was abouttwo- to three-
fold enhanced by cotreatment with TNF-a, ILl, or LPS.
N02- represented 58.2 ± 6.3% (mean of 36 cultures ±
SD) of the total amount of N02 - + N03 - , as calculated
from the values given in Fig. 1. TNF-a, IL1, or LPS were
nearly ineffective as single stimuli. However, in the case of
ILl, 10 U/ml was sufficient to enhance the IFN-'y effect,
and 100 U/ml had only a slightly better costimulatory effect
(Fig. 1). For LPS, optimal costimulation of 50 U/ml ofIFN-y
was achieved at 100 ng/ml. LPS doses higher than 100 ng/ml
did not further enhance the effect of IFN-y. Maximal produc-
tion of N02- was observed upon treatment of cells with
50 U/ml IFN--y in combination with 500 U/ml of TNF-a
(Fig. 1). This cytokine combination was therefore used in
further experiments.
Fig. 2 shows the time course of N02- and N02 - +
N03- formation upon stimulation with 50 U/ml of IFN-y
in combination with either 500 U/ml TNF-a, 100 U/ml
ILl, or 10 Ag/ml LPS. Despite the cytotoxic effects of these
cytokines (see below), which can be observed after >72 h,
there is a steady increase of N02- and N02 - + N03 - in
the supernatants over 144 h. Protein content of control cells
was 82.0 t 4.0 Ag (mean of three cultures ± SD) at the
beginning of the experiment, and 80.6 t 5.0 jig (three cul-
tures) after 144 h. Protein values were not decreased by treat-
ment with cytokines for 72 h (IFN-y/TNF-a, 82.0 ± 5.3
wg; IFN-y/llrl, 77.3 ± 1.1 Ag; IFN-y/LPS, 78.0 ± 2.0
100
80
60
40
20
Figure 1 .
￿
Formation of N02- (A)
and N02- + N03- (BI by murine
fibroblasts as a function ofIFN-y con-
centration and enhancement of the
IFN--y effect by TNF-a, ILl and LPS.
ConfluentmonolVm were treated with
various doses ofIFNJy either alone (0)
° z
￿
or in combination with 500 U/ml of
N
￿
TNF-a ("), 10 U/ml (0), or 100-U/
z°
￿
ml (0) of Ib1, or 100 ng/ml of LPS
(A) for 72 h. The results shown are
means ± SD of triplicate cultures of
one of three similar experiments in
micromoles per liter. N03- was enzy-
matically reduced to N02- , which
was detected by the Griess-reaction (see
Materials and Methods).
0 EAg [three cultures]) as compared with controls. After 144 h,
an rv20% reduction of protein content could be observed
in cytokine-treated cells (IFN-y/TNF-a, 62.6 ± 2.3 jig;
IFN-y/II,l, 63.3 ± 1.1 Etg; IFN-y/LPS, 62.6 ± 3.0 Ag [three
cultures]). Again, NO2 - was formed to 59 ± 11% (mean
of 48 cultures ± SD) of N02 - + N03 - (Fig. 2).
Dependence ofthe Formation ofN02- and NO.,- on L-argi-
nine. When fibroblasts were stimulated with 5 U/ml of
IFN-y plus 500 U/ml of TNF-a in culture medium without
L-arginine (see Materials and Methods), formation of N02-
was reduced to 1.8 ± 0.8 Amol/liter. In the presence of
L-arginine (2.4 mM) 38.5 ± 4.0 Amol/liter(mean of six cul-
tures ± SD) of N02 - was formed. NO2 - + N03 - was
reduced from 59.3 ± 5.1 wmol/liter in the presence of
L-arginine to 5.5 ± 2.7 p,mol/liter when stimulated without
L-arginine (mean of six cultures ± SD, p < 0.0001, student's
t test) .
The L-arginine analogue NMA inhibited cytokine-induced
formation of N02 - and N02- + N03 - in a dose-
dependent way (Fig. 3). Already, 25 14M of NMA was
sufficient to decrease the amount of N02 - significantly
from 38.4 ± 1.1 Amol/liter to 28.2 ± 0.7 p,mol/liter (mean
of three cultures ± SD, p < 0.001). Production of N02-
+ N03- was impaired in parallel. About 60 AM NMA was
necessary for a 50% inhibition of nitrogen oxide formation
(Fig. 3).
Effect of Modulation of Pteridine Synthesis on Formation of
N02- and N02- + N03-. Data given in Table 1 dem-
onstrate that formation of N02 - upon treatment with
IFN-y alone or in combination with TNF-ci, IIJl, or LPS
was significantly decreased by treatment of cells with DAHP
This compound inhibits GTP-cyclohydrolase I, the key en-
zyme of tetrahydrobiopterin synthesis (22). The effect of
IFN-y on N02- formation was thereby decreased to 22%
(p < 0.0001), the effect of combined stimuli was reduced to
130-50% (p < 0.001 for IFN-y/IIr1 and IFN-y/LPS; p <
0.0001 for IFN-y/TNF-a). Addition of 100 AM sepiapterin,
which provides tetrahydrobiopterin via a salvage pathway (2),
reversed the effect of DAHP. Further, when given without
DAHP, sepiapterin enhanced the effect of cytokine combina-
tions on N02- formation by 20-40%. In the case of IFN-y
alone, no such stimulation was observed (Table 1). Uncon-
jugated pteridines not yielding tetrahydrobiopterin (2), such
as pterin 6-carboxylic acid and isoxanthopterin, did not
influence cytokine-induced N02- formation or the effects
of DAHP (Table 1).
Table 2 relates these findings to intracellular biopterin con-
centrations. Treatment of fibroblasts with IFN-y/TNF-a
resulted in an about threefold increase of intracellular tetra-
hydrobiopterin levels. Sepiapterin was converted into tetra-
hydrobiopterin in untreated control cells as well as in cells
treated with IFN-y/TNF-a. This conversion occurs due to
sepiapterin reductase and further reduction of 7,8-dihydro-
s
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Figure 2. Time course of N02-
(left) and N02- + N03 - (right) in-
duction by murine fibroblasts treated
with cytokine combinations. Confluent
monolayers were stimulated with 50
U/ml of IFN-y in combination with
either 500 U/ml of TNF-a (0), 100
U/ml ofIbl (0), or 10 wg/ml ofLPS
(0). Supernatants were harvestedat in-
dicated time points, and N02- and
N02- + N03- were determined as
described in Materials and Methods,
using the Griess reagent. Values are
means oftriplicatecultures t SD from
one of two similar experiments.
NMA (umol/1)
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Effect of NMA on N02- (O) and N02- + N03 - (0)
production in cytokine-treated murine fibroblasts. Confluent monolayers
were pretreated with different concentrations ofNMA for 24 h and then
stimulated by 50 U/ml of IFN-y plus 500 U/ml of TNF-a. After 72 h,
N02 - and N02- + N03- were detected in supernatants by the Griess
reaction (see Materials and Methods). One of two experiments showing
the mean of triplicate cultures :t SD is presented here.Table 1.
￿
Influence of DAHP, Sepiapterin (SP), Pterin 6-carboxylic Acid (PCA), and Isoxanthopterin (IX)
on Cytokine-induced Formation of N02-
Confluent monolayers were treated with DAHP, pteridines, or both in thepresence of IFN-,yalone or in combination with TNF-a, IL-1, or LPS
for 72 h. N02- was determined in supernatants as detailed in Materials and Methods. Values are means of triplicate cultures ± SD from one of
three similar experiments. Control cells did not produce any detectable N02- when treated with pteridines or DAHP.
' 100 AM sepiapterin.
t 5 mM DAHP.
S 100 AM pterin 6-carboxylic acid.
n 100 PM isoxanthopterin.
Table 2.
￿
Influence of DAHP, Methotrexate (MTX), and Sepiapterin (SP) on Synthesis of Biopterin and N02- + N03-
Confluent monolayers, grown in 25-cmz culture flasks, were treated with various additives and cytokines for72 h. Total intracellular biopterin was
determined with HPLC after iodine oxidation at acidic pH. The amount of biopterin plus 7,8-dihydrobiopterin was assessed by iodine oxidation
at alkaline pH. Values in parantheses give the percentage of tetrahydrobiopterin, whichwas calculated from the ratio of totalbiopterin to biopterin
plus 7,8-dihydrobiopterin. Nitrogen oxides were determined in supernatants. For experimental details, see Materials and Methods. N02- in super-
natantswas 47 t 10% ofN02- + N03- (mean of 36 cultures t SD). Values aremeans of triplicate cultures ± SD from oneof two experiments.
" 100 14M sepiapterin.
t 5 mM DAHP.
S 10 AM methotrexate plus 40 AM thymine and 100 PM inosine.
150 U/ml IFNJy + 500 U/ml TNF-a.
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Additive
500 U/ml
IFN-y
N02-
50 U/ml IFN-,y
+
500 U/ml TNF-a
50 U/ml IFN-,y
+
500 U/ml IL-1
50 U/ml IFN-y
+
10 hg/ml LPS
Pmol/liter
None 18.3±0.6 38.8±1.4 39.5±2.6 34.2±1.7
SP" 16.1± 1.0 57.9±2.9 53.0±6.1 40.8±1.3
DAHP± 4.1 ± 0.5 12.0 ± 1.6 18.2 ± 1 .0 16.6 ± 1.0
SP + DAHP 17.0 ± 1.2 49.1 ± 0.5 38.2 ± 3.1 36.9 t 1.8
PCAS ND 34.0 ± 0.4 ND ND
PCA + DAHP ND 13.1 t 1.3 ND ND
IXI ND 34.9 ± 5.5 ND ND
IX + DAHP ND 12.0 ± 0.5 ND ND
in Cytokine-treated Murine Fibroblasts
N02- +NO3-
Treatment Total intracellular biopterin in supernatants
pmol/mg amol/liter
None 18.7 ± 1 .0 (96.1 t 5.7) ND
SP" 5,358.0 t 413 .4 (94.0 t 0.5) ND
DAHP# + SP 3,801.3 t 149.6 (89.9 ± 0.1) ND
MTXS 18.7 t 1 .6 (56.9 ± 4.5) ND
IFN-y/TNF-a11 57.9 t 3.0 (89.9 t 2.1) 127.2 t 11 .6
IFN-y/TNF-a+SP 1,661.5 t 239.9 (95 .5 ± 1.4) 197.8 t 17.3
IFN-y/TNF-a+DAHP 24.4 t 4.3 (>98) 72.7 t 8.1
IFN-y/TNF-a+DAHP+SP 1,757.8 ± 541 .2 (91 .8 ± 4.0) 131.0 t 13.3
IFN-y/TNF-a +MTX 53.5 t 1 .0 (73.5 ± 3.0) 124.2 t 15.2
IFN-y/TNF-a+MTX+SP 153.4 t 27.7 (18.4 t 8.4) 70.0 t 15.9
IFN-y/TNF-a+DAHP +MTX 16.0 t 5.5 (81 .1 t 0.9) 62.6 ± 14.0
IFN-y/TNF-a +DAHP +MTX+SP 180.3 ± 2.7 (14.0 t 11.9) 20.1 t 5.6biopterin into tetrahydrobiopterin by dihydrofolate reductase
(EC 1.5.1.3) (2) . DAHP reduced intracellular tetrahydrobi-
opterin levels by -50%. Concurrent addition ofDAHP and
sepiapterin resulted in high intracellular tetrahydrobiopterin
levels, restoring the inhibition of nitrogen oxide formation
by DAHP. This reversal was inhibited by methotrexate, which
interferes with formation of tetrahydrobiopterin from sepi-
apterin by inhibition of dihydrofolate reductase (2), thus
leading to the accumulation of dihydrobiopterin. Intracel-
lular accumulation of dihydrobiopterin even had an inhibi-
tory effect on synthesis of N02- and N02- + N03 - , as
can be seen from comparison of the effects of methotrexate
alone or together with sepiapterin in IFN-y/TNF-tx-stimu-
lated cells (p < 0.01) (Table 2). This may occur due to inhibi-
tion of GTP-cyclohydrolase I by dihydrobiopterin (23). As
a consequence, the combination of DAHP, methotrexate, and
sepiapterin had the highest inhibiting potency.
Cell Viability.
￿
Cytokine-induced formation of nitrogen
oxides leads to inhibition of aconitase (EC 4.2.1.3) in tumor
Confluent monolayers of murine fibroblasts were grownin 96-well plates and treated with IFN-y/TNF-a in absence or presence of DAHP, sepiap-
terin (SP), high doses of L- or D-argininewith or without NMA, and in L-arginine-deficient medium. At the indicated time points, cells were stained
with methylene blue, and OD at 620 nm was determined after solubilizing the dye with 0.33 M HCl (see Materials and Methods). Values are ex-
pressed as percent of viable cells relative to untreated controls ( =100%a) and give the mean of eight wells ± SD determinedin one of three similar
experiments. Controls after 96 h were 112 t 7 for sepiapterin, 108 ± 7 for DAHP, 96 ± 7 for NMA, 94 t 4 for NMA plus 10 MM L-arginine,
98 ± 7 for NMA plus 10 MM D-arginine, 102 ± 6 for 10 MM L-arginine, 96 ± 5 for 10 MM D-arginine, and 95 t 7 for L-arginine-deficient me-
dium. N02- in the respective wells was determined using the Griess reaction.
" 50 U/ml IFN-y + 500 U/ml TNF-a.
# + 100 AM sepiapterin.
S + 5 mM DAHP.
II + 250 AM NMA.
I + 250 AM NMA + 10 MM. L-arginine.
+ 250 AM NMA + 10 mM D-arginine.
## + 10 MM L-arginine.
SS + 10 MM D-arginine.
IIN Stimulated in L-arginine-deficient medium.
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cells (24) as well as in activated macrophages (15, 25). Fur-
ther, it was reported previously, that IFN-y alone or in com-
bination with IIrl, TNF-ci, or LPS is cytotoxic for murine
fibroblasts (26, 27). We therefore studied the effect of IFN-
y/TNF-a on cell viability in the absence or presence ofDAHP
or sepiapterin (Table 3). After incubationfor 96 h with IFN-
y/TNF-a, a decrease of cell viability to -50% became ap-
parent. The same was observed with IFN-y in combination
with IL.1 or LPS, and was less pronounced with IFN-y alone
(not shown). Table 3 shows that the cytotoxic effect of
IFN-y/TNF-oc could be partially reversed by simultaneous
treatment with DAHP (p < 0.01). Concurrent treatment with
sepiapterin restored the cytotoxic effect of IFN-y/TNF-a,
thus paralleling the effects on N02- formation. On control
cells, neither DAHP nor sepiapterin couldinfluence cell via-
bility (Table 3). The cytotoxic effect of IFN-y/TNF-ac was
also reduced by treatment with NMA or by withdrawal of
L-arginine. This effect of NMA was reversed by addition of
L-argininebut not by D-arginine (Table 3). Further, addition
Table 3. Influence of DAHP, Sepiapterin, and Arginine on Cell Viability of Murine Fibroblasts Treated with Cytokines
Relative cell viability after:
NOZ- after
Treatment 48 h 72 h 96 h 96 h
70 umol/liter
None 100 t9 100±7 100± 13 3.5±1.4
IFN-,y/TNF-a' 86 t8 73±4 45 t6 57.4±3.9
IFN-y/TNF-a + SP 80 t6 75±10 50 t6 83.0±6.7
IFN-y/TNF-a + DAHPS 91 t6 89 t6 70 t7 21.3±3.2
IFN-y/TNF-a + SP + DAHP 77±5 65±4 54 t6 69.1±9.4
IFN-y/TNF-a + NMAII 81 ± 4 71 ±3 78 ± 7 15.0 ± 2.3
IFN-y/TNF-a + NMA + L-ARG 77±12 68 t9 47 t2 65.9±3.1
IFN-y/TNF-a + NMA + D-ARG" 94 t6 95±5 88 t4 9.3±2.4
IFN-y/TNF-a + L-ARG## 70 t3 55 t2 22 t5 71.4±5.4
IFN-y/TNF-a + D-ARGSS 94±6 94 t5 89 t3 8.8±1.2
IFN-y/TNF-a without L-ARGIIII 86 t6 88 t5 89 t3 3.9±1.2of10 mM L-arginine but not ofD-arginine to cytokine-treated
cells in absence of NMA resulted in the highest cytotoxic
effect (Table 3) (p < 0.0001 as compared with NMA plus
10 MM L-arginine). Cell viability was significantly correlated
to N02 - levels in supernatants of the respective wells (Table
3), as determined by linear regression analysis (R = -0.78,
p < 0.000001; 144 samples) and Spearman Rank correlation
(R = -0.84, p < 0.000001; 144 samples) .
Discussion
In this report, we demonstrate that murine fibroblasts are
capable to produce N02 - and N03- from L-arginine upon
stimulation with IFN-y. This effect of IFN-y is enhanced
up to threefold by costimulation with TNF-cr, ILI, or LPS.
So far, cytokine-induced formation of nitrogen oxides has been
observed in murine macrophages, murine macrophage cell
lines (12-15, 28), rat Kupffer cells, rat hepatocytes (29, 30),
and murine endothelial cells (31). As in murine macrophages,
N02 - is formed in fibroblasts to -50% of the totally de-
tectable N02- + N03 - (13). Further, fibroblasts produce
N02 - and N03 - to an extent comparable with that found
for macrophages (13), macrophage cell lines (28), and en-
dothelial cells (31). In murine macrophages, the effect ofIFN-y
on formation of nitrogen oxides was enhanced by TNF-a,
TNF-fl, or LPS but, in contrast to our results with fibro-
blasts, not by IM (14, 15). The significance of this difference
is unclear.
N02- and N03 - originate from the oxidation of L-argi-
nine to citrulline. This reaction can be inhibited by theL-argi-
nine analogue NMA (32, 33). The unstable intermediate
formed initially is nitric oxide, which is converted to N02-
and N03- in the presence of oxygen (34). Nitric oxide has
been identified as a cytotoxic effector molecule of activated
murine macrophages (35, 36).
Recently, it was shown in preparations from cytosol of
activated macrophages that oxidation of L-arginine requires
tetrahydrobiopterin (8, 9). Tetrahydrobiopterin was suggested
to take part in the initial step of the reaction, resulting in
N-hydroxylation of L-arginine (8, 9). It was further shown
that murine macrophages contain tetrahydrobiopterin (8, 9).
We show here for murine fibroblasts that cytokine-induced
formation of N02- and N03 - is paralleled by increased in-
tracellular levels of tetrahydrobiopterin. By inhibiting tetra-
hydrobiopterin de novo synthesis, usingthe GTP-cyclohydro-
lase I inhibitor DAHP (22), we could demonstrate that the
amount of intracellular tetrahydrobiopterin is limiting the
formation of N02- and N03 - . Resupplementing the co-
factor by addition ofsepiapterin, which is converted into tetra-
hydrobiopterin in the cells via a salvage pathway (2), fully
restores the formation of N02- and N03- . Methotrexate
blocks this restoring effect of sepiapterin by inhibiting di-
hydrofolate reductase, which converts dihydrobiopterm formed
from sepiapterin to the tetrahydro-derivative (2), thus un-
derlining that only the tetrahydroderivative can serve as an
active cofactor. While inhibition of tetrahydrobiopterin con-
centrations by DAHP significantly suppresses nitrogen oxide
formation, a comparatively high amount of sepiapterin, and
thus a high concentration of tetrahydrobiopterin, is neces-
sary for restoration of nitrogen oxide formation. A possible
explanation for this phenomenon could be that tetrahydrobi-
opterin generation from exogenously supplied sepiapterin may
take place in a compartment different from the site of argi-
nine hydroxylation, whereas endogenous tetrahydrobiopterin
synthesis may supply tetrahydrobiopterin directly to the
hydroxylation site.
Other unconjugated pteridines that cannot be converted
to tetrahydrobiopterin due to the lack of the 1,2'-dihydroxy-
propyl side chain at position 6 of the pterin ring (2) could
not influence formation of nitrogen oxides and the effect of
DAHP Sepiapterin also enhanced the effect ofIFN-y in com-
bination with TNF-a, IM, or LPS, but not with IFN-y
alone. Thus, it seemsthat in presence of dual activationstimuli,
the reaction forming N02 - is not saturated with tetra-
hydrobiopterin, although its synthesis is enhanced in parallel.
Taken together, the results obtained with DAHP, sepi-
apterin, and methotrexate give evidence that not only in cytosol
preparations (8, 9), but also in intact cells, tetrahydrobiopterin
is essential for the production of nitrogen oxides.
The cytotoxic effect of IFN-y in combination with TNFLoi,
ILl, or LPS on murine fibroblasts can be attenuated by
reducing formation of nitrogen oxides via inhibition of L-argi-
nine hydroxylation with NMA, via withdrawalOfL-arginine,
or via inhibition of tetrahydrobiopterin synthesis with DAHP
Addition of L-arginine and sepiapterin, respectively, restores
the cytotoxic potential ofcytokine treatment. These data in-
dicate that formation of nitrogen oxides takes part in the pre-
viously reported cytotoxic action ofIFNJy with TNF-oc, IL1,
or LPS (26, 27) on murine fibroblasts. Thus, it is not only
possible to influence formation of N02 - and N03 - by
modulation of pteridine synthesis, but also, the biological
effect of nitrogen oxides on fibroblasts.
The presented data suggest that in murine fibroblasts a
major goal for cytokine-induced pteridine synthesis is to pro-
vide cells with an essential cofactor for the formation of
nitrogen oxides from L-arginine. Nitric oxide, the initial
product of the oxidation of L-arginine, exhibits a multitude
ofbiological actions (37, 38). It remains to be seen whether
also in human cells cytokine-induced pteridine synthesis (1,
3-7) is related to oxidation of L-arginine and formation of
nitrogen oxides.
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